LONDON - Celltech Group plc announced it is closing Oxford GlycoSciences plc's flagship proteomics business, after failing to find a buyer for the unit, which it acquired when it took over Oxford GlycoSciences in April. (BioWorld International)
LONDON - Celltech Group plc announced it is closing Oxford GlycoSciences plc's flagship proteomics business, after failing to find a buyer for the unit, which it acquired when it took over Oxford GlycoSciences in April. (BioWorld International)
LONDON - Maxim Pharmaceuticals Inc. became the first to make an all-electronic submission in Europe last week, when it filed for Ceplene in combination with interleukin-2 for the treatment of advanced malignant melanoma. (BioWorld International)
